{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:46:20Z","timestamp":1790405180624,"version":"4.1.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA182311"],"award-info":[{"award-number":["R01CA182311"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA208644"],"award-info":[{"award-number":["R01CA208644"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heath Foundation"},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187532","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:37:30Z","timestamp":1510684650000},"page":"e0187532","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["STING expression and response to treatment with STING ligands in premalignant and malignant disease"],"prefix":"10.1371","volume":"12","author":[{"given":"Jason R.","family":"Baird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong D.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Cottam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom S.","family":"Leidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bryan","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marka R.","family":"Crittenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-0074","authenticated-orcid":true,"given":"Michael J.","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1473-3099(09)70108-2","article-title":"Clinician&apos;s guide to human papillomavirus immunology: knowns and unknowns","volume":"9","author":"MH Einstein","year":"2009","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajog.2011.06.105","article-title":"Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia","volume":"206","author":"DR Pachman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0020-7292(00)00389-1","article-title":"A randomized trial of interferon-alpha in cervical dysplasia","volume":"74","author":"BS Gostout","year":"2001","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"SR Hingorani","year":"2005","journal-title":"Cancer cell"},{"issue":"3","key":"ref5","first-page":"271","article-title":"Spontaneous Vulvar Papillomas in a Colony of Mice Used for Pancreatic Cancer Research","volume":"58","author":"NM Gades","year":"2008","journal-title":"Comparative Medicine"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","article-title":"Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors","volume":"76","author":"JR Baird","year":"2016","journal-title":"Cancer Res"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity","volume":"11","author":"L Corrales","year":"2015","journal-title":"Cell Rep"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"e69527","DOI":"10.1371\/journal.pone.0069527","article-title":"The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor","volume":"8","author":"MR Crittenden","year":"2013","journal-title":"PloS one"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2017.04.014","article-title":"Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control","volume":"99","author":"JR Baird","year":"2017","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/2326-6066.CIR-16-0104","article-title":"Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade","volume":"4","author":"E Moore","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hed.1130","article-title":"Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy","volume":"23","author":"D Khurana","year":"2001","journal-title":"Head & neck"},{"issue":"18","key":"ref12","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1012720108","article-title":"Identifying the cellular origin of squamous skin tumors","volume":"108","author":"G Lapouge","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.3878","article-title":"Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma","volume":"21","author":"D Nassar","year":"2015","journal-title":"Nature medicine"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/JVI.70.3.1873-1881.1996","article-title":"Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene","volume":"70","author":"R Herber","year":"1996","journal-title":"Journal of Virology"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1078-0432.CCR-0999-3","article-title":"Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice","volume":"10","author":"X-H Tang","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"38","key":"ref16","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1073\/pnas.0606698103","article-title":"Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model","volume":"103","author":"K Strati","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"ref17","first-page":"1267","article-title":"Sensitivity of the Cervical Transformation Zone to Estrogen-induced Squamous Carcinogenesis","volume":"60","author":"DA Elson","year":"2000","journal-title":"Cancer research"},{"issue":"16","key":"ref18","first-page":"4862","article-title":"Dissection of Human Papillomavirus E6 and E7 Function in Transgenic Mouse Models of Cervical Carcinogenesis","volume":"63","author":"RR Riley","year":"2003","journal-title":"Cancer research"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1172\/JCI119814","article-title":"Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1\/Fas)-CD95 ligand-induced suicide","volume":"100","author":"SA Buechner","year":"1997","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI7630","article-title":"NF-kappaB determines localization and features of cell death in epidermis","volume":"105","author":"CS Seitz","year":"2000","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ijc.2910610119","article-title":"Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha","volume":"61","author":"J Rodriguez-Villanueva","year":"1995","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"Suppl 2","key":"ref22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients","volume":"157","author":"C Ulrich","year":"2007","journal-title":"The British journal of dermatology"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0192988","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T20:58:47Z","timestamp":1603313927000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187532"}},"subtitle":[],"editor":[{"given":"Xuefeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187532","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0192988","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}